Synlogic Inc (SYBX) Stock: What Does the Chart Say?

Wednesday, January 13, 2021 10:14 AM | InvestorsObserver Analysts

Overall market sentiment has been high on Synlogic Inc (SYBX) stock lately. SYBX receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Synlogic Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SYBX!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With SYBX Stock Today?

Synlogic Inc (SYBX) stock is higher by 46.25% while the S&P 500 is down 0% as of 10:08 AM on Wednesday, Jan 13. SYBX is up $1.11 from the previous closing price of $2.40 on volume of 4,834,764 shares. Over the past year the S&P 500 has risen 15.60% while SYBX is up 36.58%. SYBX lost -$1.64 per share in the over the last 12 months.

To screen for more stocks like Synlogic Inc click here.

More About Synlogic Inc

Synlogic Inc is a biopharmaceutical company focused on advancing the drug discovery and development platform for Synthetic Biotic medicines, which are designed using synthetic biology to genetically reprogram beneficial microbes to treat metabolic and inflammatory diseases and cancer.

Click Here to get the full Stock Score Report on Synlogic Inc (SYBX) Stock.

Share this article:

Related Companies

You May Also Like